Background: Carvedilol (CD) is a β-blocker drug that is used in the treatment of hypertension, coronary diseases, etc. The official methods for the assay of CD in British Pharmacopoeia (BP) and United States Pharmacopeia (USP) include potentiometric titration and HPLC analysis, respectively. There are two different methods reported in the USP; one is for the pure CD and the other is for its tablet dosage forms. Both methods are time consuming, require stringent preparation and have specific requirements such as temperature.
Objective: The present study involves the development and validation of a simple, rapid and economical, stability-indicating RP-HPLC method for the assay of CD in pure and tablet dosage forms.
Method: A mobile phase of acetonitrile and water in a ratio of 60:40, v/v, has been used for the assay of CD at pH 2.5 giving the retention time (tR) of around 3 min. The method has been validated according to the guidelines of International Council for Harmonization (ICH) for parameters such as linearity, range, accuracy, precision, sensitivity, robustness and specificity.
Results: The results indicate that the method is linear in the range of 25-150% (6.25-37.50 µg/ml), highly accurate (100.1%), precise (<1%), robust (<1.5%) and statistically comparable to the official USP methods. Conclusion: The stress degradation studies yielded a number of degradation products with varying tR values, all different from the principle peak of CD thus indicating that the method is highly specific and reliable for the assay of CD.
Keywords: Carvedilol, HPLC stability-indicating method, tablets, USP method, validation, forced degradation.
Insights into the Pathogenesis and Intervention of Atherosclerosis
Vascular Disease Prevention Use and Safety of Calcium Channel Blockers in Obstetrics
Current Medicinal Chemistry Rationale and Design of an Observational Study to Determine the Effects of Cholecalciferol on Hypertension, Proteinuria and Urinary MCP-1 in ADPKD
Current Hypertension Reviews Pharmacological Interventions on Asymmetric Dimethylarginine, a Clinical Marker of Vascular Disease
Current Medicinal Chemistry New Developments in the Diagnosis and Management of Resistant Hypertension
Current Medicinal Chemistry Medicinal Chemistry and Pharmacology of A2B Adenosine Receptors
Current Topics in Medicinal Chemistry Relationship Between Hypertension and Atherosclerosis: From a Viewpoint of the Most Potent Vasoconstrictor Human Urotensin II
Current Hypertension Reviews Psoriasis and Vascular Risk : An Update
Current Pharmaceutical Design Role of Cytochrome P450 Metabolites of Arachidonic Acid in Hypertension
Current Drug Metabolism Diabetes, Oxidative Stress, Nitric Oxide and Mitochondria Function
Current Diabetes Reviews 20-Hydroxyeicosatetraenoic Acid is a Potential Therapeutic Target in Cardiovascular Diseases
Current Drug Metabolism Molecular and Vascular Targets in the Pathogenesis and Management of the Hypertension Associated with Preeclampsia
Cardiovascular & Hematological Agents in Medicinal Chemistry The Role of Endothelin-1 in Obstructive Sleep Apnea Syndrome and Pulmonary Arterial Hypertension: Pathogenesis and Endothelin-1 Antagonists
Current Medicinal Chemistry Pulmonary Hypertension and Right Ventricular Dysfunction in Chronic Lung Diseases: New Pathobiologic Concepts
Current Respiratory Medicine Reviews Preconception Care for Diabetic Women: Background, Barriers, and Strategies for Effective Implementation
Current Diabetes Reviews Dopamine β-Monooxygenase: Mechanism, Substrates and Inhibitors
Current Enzyme Inhibition Aorta Remodeling Due to Stretch or Turbulent Flow/Low Wall Shear Stress: Distinctly Different Biological Phenomena?
Current Cardiology Reviews Pharmacological Approaches in the Treatment of Atrial Fibrillation
Current Medicinal Chemistry Quality Based Design Approach for Improving Oral Bioavailability of Valsartan Loaded Smedds And Study of Impact of Lipolysis on the Drug Diffusion
Drug Delivery Letters Current Diagnostic Investigation in Pulmonary Hypertension
Current Respiratory Medicine Reviews